Kissei Pharmaceutical Co., Ltd.
4547.T · JPX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | ¥178,246 | ¥169,035 | ¥164,585 | ¥180,011 |
| - Cash | ¥36,324 | ¥28,823 | ¥25,169 | ¥18,667 |
| + Debt | ¥1,270 | ¥1,280 | ¥1,280 | ¥1,280 |
| Enterprise Value | ¥143,192 | ¥141,492 | ¥140,696 | ¥162,624 |
| Revenue | ¥23,640 | ¥22,191 | ¥22,661 | ¥23,203 |
| % Growth | 6.5% | -2.1% | -2.3% | – |
| Gross Profit | ¥11,608 | ¥11,080 | ¥10,947 | ¥11,720 |
| % Margin | 49.1% | 49.9% | 48.3% | 50.5% |
| EBITDA | ¥4,837 | ¥3,263 | ¥5,204 | ¥5,593 |
| % Margin | 20.5% | 14.7% | 23% | 24.1% |
| Net Income | ¥3,266 | ¥4,519 | ¥3,121 | ¥3,590 |
| % Margin | 13.8% | 20.4% | 13.8% | 15.5% |
| EPS Diluted | 78.76 | 107.87 | 72.91 | 82.99 |
| % Growth | -27% | 47.9% | -12.1% | – |
| Operating Cash Flow | – | ¥0 | ¥0 | ¥0 |
| Capital Expenditures | – | ¥0 | ¥0 | ¥0 |
| Free Cash Flow | – | ¥0 | ¥0 | ¥0 |